Related Experiment Video
Updated: Jun 12, 2026
11:49
The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
Published on: August 16, 2014
VEGF-induced corneal neovascularisation in a rabbit experimental model
L Coman1, Oana Andreia Coman, H Păunescu
1Department of Physiology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. laurentiucmn@yahoo.com
Summary
This study developed a reproducible rabbit model for corneal vascularization, revealing vascular endothelial growth factor (VEGF) as a key initiator via a non-inflammatory pathway. Dexamethasone effectively treated inflammation-induced neovascularization but not VEGF-driven angiogenesis.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Biomedical Engineering
Background:
- Corneal vascularization, a condition where new blood vessels grow into the normally avascular cornea, can impair vision.
- Existing experimental models for studying corneal neovascularization often lack reproducibility and detailed analysis capabilities.
Purpose of the Study:
- To establish a reproducible experimental model for investigating corneal vascularization.
- To develop software for digital analysis of corneal neovascularization data.
- To investigate the role of vascular endothelial growth factor (VEGF) in corneal neovascularization.
Main Methods:
- An experimental model was created using 27 rabbits with intracorneal implants (with or without VEGF) and induced corneal burns.
- A microsurgical technique and computerized imaging system with specialized software were employed for video recording and data analysis.
- Histochemical studies were performed on animal eyes.
Main Results:
- The developed model demonstrated simplicity and reproducibility.
- Vascular endothelial growth factor (VEGF) was identified as a crucial initiator and promoter of corneal vascularization through a non-inflammatory mechanism.
- Dexamethasone showed efficacy in treating inflammation-induced corneal angiogenesis but not VEGF-induced neovascularization.
Conclusions:
- The experimental model provides a robust platform for studying corneal vascularization.
- VEGF plays a significant role in initiating and promoting corneal vascularization independently of inflammation.
- Dexamethasone's therapeutic effect is specific to inflammation-driven angiogenesis.
